Skip to content
pmos·pcos

Our editorial methodology — how we write health content

You may be reading an article right now that could influence a medical decision. You deserve to know how it was written, by whom, based on which sources, and with what guarantees of freedom from conflicts of interest.

Our editorial scope

pmos-pcos.com is a general information and consultation preparation tool site. We do not diagnose. We do not prescribe treatments. We sell nothing — no supplements, no coaching programme, no online medical consultation.

Our scope is limited to: explaining PCOS/PMOS using published evidence, providing consultation preparation tools (symptom checker, tracker, doctor summary, letter, quiz), and directing readers to healthcare professionals and patient organisations. Any claim that goes beyond this scope is an error we want to correct.

Our sources — three-tier hierarchy

We classify our sources according to a strict evidence hierarchy, aligned with international evidence-based medicine (EBM) standards:

  1. Tier 1 — Official guidelines and international recommendations: Endocrine Society (PMOS guidelines 2023, updated 2026), International PCOS Guideline Group (Monash University), ESHRE, ACOG, ASRM, RCOG, NICE, NHS Clinical Knowledge Summaries (CKS), CDC. These constitute our primary reference for any statement about PMOS diagnosis, treatment, or follow-up.
  2. Tier 2 — Meta-analyses and systematic reviews: Cochrane Collaboration, JAMA, The Lancet, NEJM, Journal of Clinical Endocrinology & Metabolism (JCEM), Frontiers in Endocrinology, Fertility & Sterility, Human Reproduction. Cited to support or nuance Tier 1 recommendations.
  3. Tier 3 — Major randomised controlled trials (RCTs): Legro et al. 2014 (PPCOS II, metformin vs letrozole), Truveta 2025 (GLP-1 and PCOS), and other landmark trials. Cited to complement meta-analyses, never as a replacement.

All clinical statements are sourced inline with the lead author name and year. The Sources page contains the complete bibliography for pillar pages.

Our editorial process

Every medical content page follows this pathway before publication:

  1. Literature review — identification of relevant Tier 1 and 2 sources, verification of guideline publication dates.
  2. Writing by the editorial team — written in clear, non-judgmental English, aligned with identified sources. Systematic avoidance of inaccessible jargon.
  3. Internal cross-check — verification of claims, figures, and links to original sources.
  4. Medical advisory review — pages covering drug treatments (metformin, spironolactone, letrozole), insulin resistance, and HOMA-IR calculation are reviewed by a consulting scientific advisory board (endocrinologist). The reviewer's identity and review date will be published on relevant pages once this step is completed.
  5. Patient review — a circle of patient reviewers validates clarity, tone, and absence of stigmatising language.
  6. Dated publication — every page displays its publication date and last revision date.

Any content produced with AI assistance undergoes complete human review before publication. No clinical claim is published without verification against primary sources. This is a non-negotiable standard.

Conflicts of interest

The pmos-pcos.com editorial team has, to date, no financial or commercial relationship with:

  • The pharmaceutical industry (no laboratory has sponsored us, directly or indirectly);
  • Dietary supplement manufacturers (inositol, berberine, NAC, zinc, vitamin D, etc.);
  • Private medical laboratories;
  • Telemedicine platforms;
  • Health or nutrition coaching programmes.

The site is funded by the founder's personal investment. It contains no advertising, no affiliate links, no product or service sales. If any monetisation were introduced, it would be explicitly disclosed on the About page.

Update frequency

Medical content pages are subject to systematic review every 12 months. Any major evolution in international recommendations triggers an immediate review. Example: the PMOS/PCOS renaming officially recognised in May 2026 triggered a complete site revision within two weeks.

Every page displays its last revision date. Our commitment: no medical content page left more than 18 months without documented revision. If you spot a page without a recent date, please tell us — we correct promptly.

Editorial safeguards

Certain terms and formulations are explicitly prohibited in our content, as they generate unfounded expectations or stigma:

  • “Curing” PCOS/PMOS — the condition is managed and controlled long-term; it is not cured in the medical sense.
  • “Detox” — a term without scientific basis in the hormonal context.
  • “Miracle protocol” / “anti-PCOS plan” — formulations promising results not guaranteed by available clinical data.
  • Recommendations contradicting Endocrine Society, Monash, NICE, or ACOG guidelines.
  • Personal or anecdotal opinions presented as established clinical facts.

All AI-assisted content undergoes complete human editorial review. No clinical claim is published without verification against primary sources.

Personal data and tools

All our interactive tools (symptom checker, phenotype quiz, doctor summary, symptom tracker, cycle tracker, HOMA-IR calculator, Ferriman-Gallwey score, doctor letter) run entirely locally in your browser. No health data is transmitted to our servers or to third parties. Your data never leaves your device. For details, see our privacy policy.

How to contribute or report an error

Our correction policy is simple: if you spot a factual error, an outdated source, stigmatising language, or an inaccuracy, we correct within 48 hours and note the correction at the bottom of the relevant page.

Are you a healthcare professional who would like to review a page before publication? Are you a patient who wishes to share your experience anonymously to enrich the Testimonials page? Contact us via the About page.

Why this transparency?

On the subject of PCOS/PMOS, misinformation is widespread and easily monetised: TikTok is full of “cortisol cleanses” and “hormone detoxes,” Amazon abounds with supplements promising syndrome “reversal,” and some coaching sites offer expensive personalised protocols with no clinical basis. This misinformation delays diagnoses, costs money, and — above all — isolates.

Our editorial choice is to offer the opposite: sources verifiable in one click, total commercial neutrality, explicit safeguards. We cannot replace your doctor. But we can help you arrive at your next appointment prepared, informed, and confident.

You will make your decisions with a healthcare professional — our role is to give you the right tools for that conversation.